[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"alopecia-drugs\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:alopecia-drugs":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":32,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100537860",false,"NCT06283316","Systemic Treatments for Alopecia Areata Registry","STA2R","Inclusion Criteria:\n\n* Diagnosed with alopecia areata;\n* Starting\u002Fusing a systemic treatment for alopecia areata;\n* Informed consent for registry participation obtained from patient and\u002For caretaker.\n\nExclusion Criteria:\n\n* Not sufficiently capable of understanding the Dutch language;\n* Not willing to participate.","ALL","16 Years",{"count":18,"type":19},10000,"ESTIMATED","50 Years","OBSERVATIONAL","A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.",[24,25,26,27,28,29,30,31],"Alopecia Areata","Alopecia Totalis","Alopecia Universalis","Hair Loss","Hair Diseases","Alopecia","Alopecia Drugs","Autoimmune Diseases",[24,25,26,33,34],"Systemic treatment","Registry","RECRUITING","2024-02-27",{"date":38,"type":39},"2024-02-28","ACTUAL",{"date":41,"type":39},"2024-01-17",{"date":43,"type":19},"2099-12-31",{"name":45,"class":46},"Erasmus Medical Center","OTHER",""]